January 31, 2026 · Form 4 insider transaction
Barrett Elizabeth A. bought 153,195 shares of UROGEN PHARMA LTD at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 19 days after the transaction.
Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.; 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2027, January 31, 2028 and January 31, 2029.